Related Experiment Videos

[Clinical observations on propranolol use for paediatric airway hemangiomas]

Saturnino Santos1, Antonio Torrelo, Amalia Tamariz-Martel

  • 1Servicio ORL, Hospital Infantil Universitario Niño Jesús, Madrid, España. satursantos@gmail.com

Acta Otorrinolaringologica Espanola
|March 30, 2010
PubMed

Insights

Propranolol offers a safe and effective treatment for children with subglottic hemangiomas, rapidly improving respiratory symptoms without severe side effects. This approach provides a promising alternative for managing these challenging airway conditions.

Area of Science:

  • Pediatric Otolaryngology
  • Vascular Anomalies
  • Pharmacological Interventions

Context:

  • Subglottic hemangiomas in children present significant treatment challenges.
  • Traditional therapies lack consensus and carry risks of severe side effects.
  • Emerging evidence suggests propranolol as a potential therapeutic option.

Purpose:

  • To evaluate the efficacy and safety of propranolol in treating pediatric airway hemangiomas.
  • To report clinical experience with propranolol for symptomatic subglottic hemangiomas.
  • To assess the impact of propranolol on respiratory symptoms and need for further interventions.

Summary:

  • Six children with symptomatic airway hemangiomas were treated with propranolol.
  • All patients experienced dramatic improvement in respiratory symptoms.
  • No additional interventions were required post-propranolol treatment.

Impact:

  • Propranolol demonstrates significant potential as a first-line treatment for pediatric airway hemangiomas.
  • This treatment offers rapid symptom resolution and avoids severe adverse events.
  • The findings support propranolol as a safe and effective therapeutic strategy.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...